Interaction of Avilamycin with Ribosomes and Resistance Caused by Mutations in 23S rRNA

The antibiotic growth promoter avilamycin inhibits protein synthesis by binding to bacterial ribosomes. Here the binding site is further characterized on Escherichia coli ribosomes. The drug interacts with domain V of 23S rRNA, giving a chemical footprint at nucleotides A2482 and A2534. Selection of...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Kofoed, Christine B., Vester, Birte
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Mechanisms of Action: Physiological Effects
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC128742/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12384333/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.11.3339-3342.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!